Publications by authors named "S Andres"

Background: Upper limb impairment post-stroke often leads to a predominant use of the less affected arm and consequent learned disuse of the affected side, hindering upper limb outcome. Wearable sensors such as accelerometers, combined with smart reminders (i.e.

View Article and Find Full Text PDF

Advances in knowledge about clinical features, physiology, and underlying immunology are leading to targeted therapies and a new era of therapies. Biological treatments for severe asthma have changed the way this disease is managed, especially in patients who do not respond adequately to conventional treatments with corticosteroids and bronchodilators. These treatments block the action of different molecules involved in the immune response and in the inflammation of the airways, bronchoconstriction, bronchial hyperresponsiveness, and excessive mucus production.

View Article and Find Full Text PDF

Secondary adrenal insufficiency is a life-threatening condition that may arise in the setting of iatrogenic Cushing syndrome. Intra-articular corticosteroid injections (IACs) are a standard treatment for osteoarthritis, and they carry a high risk of secondary central adrenal suppression (SAI). We present the case of a 43-year-old woman who was referred to reproductive endocrinology for evaluation of abnormal uterine bleeding with a provisional diagnosis of perimenopause.

View Article and Find Full Text PDF
Article Synopsis
  • Research indicates that DNA repair and mitochondrial health pathways are linked to HD, with study findings showing elevated DNA damage even before the disease manifests.
  • Findings reveal that mutation carriers have lower levels of poly ADP-ribose (PAR) in their cerebrospinal fluid, and while wild-type HTT boosts PARP1 activity, the mutant form does not, highlighting potential pathways for developing early preventive treatments for HD.
View Article and Find Full Text PDF